MedTrace Logo

Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer

NCT06827340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2025-02-14

No results posted yet for this study

Summary

WB-MRI is a next-generation imaging technique standardized with the first version of MET-RADs-P guidelines.This narrative review aims to analyse the main scientific evidence available in the literature, explaining what WB MRI is and showing its decisive role in metastatic PC.

Conditions

  • Prostate Cancer (Adenocarcinoma)

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Lorenzo Bianchi · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-01-01
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06827340 on ClinicalTrials.gov